SLC16A1 and sclerosing cholangitis: Here we report, for the first time, information about SLC16A1 expression at both the mRNA and protein levels in a wide range of liver pathologies, i.e., of viral (hepatitis C), toxic (alcoholic liver disease), cholestatic (primary biliary cirrhosis, primary sclerosing cholangitis), and inflammatory (autoimmune hepatitis) origin.